mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.03 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.03 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.03 |